Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Care

• Publication date

  2000-04-14

• Fields of study

  Medicine

• Identifiers
  PMID 10860187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Early Atherosclerosis Is Retarded by Improved Long-Term Blood Glucose Control in Patients With IDDM

  1996cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

  1992cited by this paper
• Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies

  1991cited by this paper
• Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

  1991cited by this paper
• Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications Trial

  1988cited by this paper
• The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.

  1986cited by this paper
• Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability

  1970cited by this paper
• THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

  1965cited by this paper

• Recommendations for Screening, Risk Stratification, and Targeted Treatment for Diabetic Kidney Disease in the UAE

  2026cites this paper
• Validation of the IHE type 2 diabetes cohort model in the Japanese clinical setting

  2025cites this paper
• Occurrence and Contributing Factors for Amputation in Individuals Hospitalized with Acute Diabetic Foot Complications at a Tertiary Care Center in Western India, and Its Association with Glycemic Status on Admission

  2025cites this paper
• Consensus statement on novel glucose-related metrics obtained through advanced medical devices: English version

  2025cites this paper
• Plin5: A potential therapeutic target for type 2 diabetes mellitus

  2025cites this paper
• Glucose Variability and Postprandial Hyperglycaemia After Breakfast in Children and Young People With Type 1 Diabetes

  2025cites this paper
• Glycemic control and prostate antigen levels in individuals with diabetes based on NHANES data

  2025cites this paper
• Dynamic Prediction of Postprandial Glycemic Response and Personalized Dietary Interventions Based on Machine Learning.

  2025cites this paper
• Management of diabetic tractional retinal detachments: surgical experiences from a large tertiary academic institution

  2025cites this paper
• The association between uncontrolled hyperglycemia (Type-2 Diabetes) and cardiovascular sequelae in patients with and without insulin

  2024cites this paper
• Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease

  2024cites this paper
• Diabetes mellitus tipo 2

  2024cites this paper
• Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents

  2024cites this paper
• Poor Glycemic Control Affecting Screening of Prostate Carcinoma

  2024cites this paper
• Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners

  2024cites this paper
• Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial

  2024cites this paper
• Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan

  2024cites this paper
• Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease.

  2024cites this paper
• Multiomic study of the protective mechanism of Persicaria capitata (Buch.-Ham. ex D.Don) H.Gross against streptozotocin-induced diabetic nephropathy in Guizhou miniature pigs.

  2024cites this paper
• 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

  2023cites this paper
• Preoperative HbA1c and Blood Glucose Measurements in Diabetes Mellitus before Oral Surgery and Implantology Treatments

  2023cites this paper
• Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure.

  2023cites this paper
• Bi-weekly Glycated Albumin Measurement was Useful to Encourage Behavioral Changes in People with Type 2 Diabetes Mellitus

  2023cites this paper
• Relationship between glycemic variability and cognitive function in lacune patients with type 2 diabetes

  2023cites this paper
• Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial

  2023cites this paper
• Machine Learning Approach to Drug Treatment Strategy for Diabetes Care

  2023cites this paper
• Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J‐mono study

  2023cites this paper
• Hepatalin: The missing link in prediabetes, obesity, and type 2 diabetes.

  2023cites this paper
• Néphropathie diabétique

  2023cites this paper
• Adherence to Mediterranean Diet Is Associated With Better Glycemic Control in Children With Type 1 Diabetes: A Cross-Sectional Study

  2022cites this paper
• Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease

  2022cites this paper
• Pathophysiology and management of hypoglycemia in diabetes

  2022cites this paper
• Emulating the GRADE trial using real world data: retrospective comparative effectiveness study

  2022cites this paper
• Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus

  2022cites this paper
• Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?

  2022cites this paper
• Glycated albuminandHbA1cas markers of lower extremity disease inUS adults with and without diabetes.

  2022cites this paper
• Single Nucleotide Polymorphism in the ADIPOQ Gene Modifies Adiponectin Levels and Glycemic Control in Type Two Diabetes Mellitus Patients

  2022cites this paper
• The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy

  2022cites this paper
• Diabetic Retinopathy Is a Predictor of Progression of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents.

  2022cites this paper
• Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?

  2022cites this paper
• Childhood diabetes mellitus and early-onset kidney diseases later in life: a nationwide population-based matched cohort study

  2022influential citation
• Diabetic nephropathy: Pathogenesis to cure.

  2022cites this paper
• Status of diabetes control and knowledge about diabetes in patients.

  2021cites this paper
• Analysis of risk factors for progression of diabetic nephropathy in patients with type 2 diabetes

  2021cites this paper
• A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials

  2021cites this paper
• Indications and Outcome of Admission of Patients with Diabetes Into Benha University Hospitals, Egypt: A Prospective Study.

  2021cites this paper
• Laser-acupuncture to control blood glucose in Type II Diabetes: a randomized clinical trial

  2021cites this paper
• Current concepts and clinical importance of glycemic variability.

  2021cites this paper
• Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter

  2021cites this paper
• Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial

  2021cites this paper
• A target HbA1c between 7 to 7.7% reduces macrovascular events in T2D regardless of duration of diabetes: a meta-analysis of randomized controlled trials

  2021cites this paper
• Renal outcomes associated with glucose-lowering agents: Systematic review and meta-analysis of randomized outcome trials.

  2021cites this paper
• Discordance between fasting plasma glucose and A1c in the diagnosis and management of diabetes

  2021cites this paper
• Status of diabetes control and knowledge about diabetes in patients.

  2021cites this paper
• Glycaemic Monitoring in Diabetic Kidney Disease – Is HbA1c Reliable?

  2021cites this paper
• Epidemiological characteristics of diabetic kidney disease in Taiwan

  2021cites this paper
• The putative causal effect of type 2 diabetes in risk of cataract: a Mendelian randomization study in East Asian

  2021cites this paper
• Diabetes and conversational agents: the AIDA project case study

  2021cites this paper
• Correlation of Risk Factors with Severity of Diabetic Retinopathy - A Retrospective Study

  2020cites this paper
• Uric acid and inflammation in kidney disease.

  2020influential citation
• Relationship of type 2 diabetes mellitus and cardiovascular pathology: significance of glycemic control on the way to solving the problem

  2020cites this paper
• Translating the statistical benefits of SGLT-2 inhibitors on cardio-renal outcomes into clinical practice

  2020cites this paper
• Genetic Testing of PAX8 Mutations Associated with Thyroid Dysgenesis in Chinese Congenital Hypothyroidism Patients.

  2020cites this paper
• GLP-1 receptor agonist on cardiovascular complications of diabetes mellitus.

  2020cites this paper
• DMSO_A_261486 2729..2741

  2020cites this paper
• Monocyte CD36 expression associates with atherosclerotic burden in diabetes mellitus.

  2020cites this paper
• Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease

  2020cites this paper
• Abstract. Effects of glucagon-like peptide-1 (GLP-1) receptor agonist on cardiovascular complications of diabetes

  2020cites this paper
• Glycemic Control and Future Perspectives for Treatment

  2020cites this paper
• Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in China

  2020cites this paper
• Diabetic Kidney Disease

  2020cites this paper
• Diabetes and Metabolism

  2020cites this paper
• Short-term Renoprotective Effect of SGLT-2 Inhibitor for Renal Function and Albuminuria in Type 2 Diabetes: a Retrospective Study

  2020cites this paper
• Intensive Insulin Therapy (Basal-Bolus)

  2020cites this paper
• Approach to Chronic Kidney Disease in the Diabetic Patient

  2020cites this paper
• Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy

  2020cites this paper
• A Review of Research Progress on Glycemic Variability and Gestational Diabetes

  2020cites this paper
• Antidiabetic drugs and blood pressure changes.

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes

  2020cites this paper
• Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy.

  2020cites this paper
• EFFICACY AND SAFETY OF BASAL INSULIN THERAPY IN ROMANIAN PATIENTS WITH TYPE 2 DIABETES IN REAL-LIFE SETTINGS: A SUB-GROUP ANALYSIS OF DUNE STUDY.

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Satisfaction with Quality of Life in older Adults with Type 2 Diabetes

  2020cites this paper
• Effects of thromboxane prostanoid receptor deficiency on diabetic nephropathy induced by high fat diet and streptozotocin in mice.

  2020cites this paper
• DMSO_A_242148 4651..4659

  2020cites this paper
• Impact of primary aldosteronism on renal function in patients with type 2 diabetes

  2020cites this paper
• Autoimmune Thyroid Disease is Associated with a Lower Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetic Mellitus

  2020cites this paper
• Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

  2020cites this paper
• Thyroid dysfunction in patients with diabetic retinopathy.

  2020cites this paper
• Sodium-Glucose Cotransporter-2 Inhibitor Immediately Decreases Serum Uric Acid Levels in Type 2 Diabetic Patients

  2020cites this paper
• Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin.

  2020cites this paper
• High Proportion of Adults With Type 2 Diabetes and Poor Glycated Hemoglobin Perceived That Their Diabetes Control Was Excellent.

  2019cites this paper
• DMSO_A_214288 1225..1237

  2019cites this paper
• Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease

  2019cites this paper
• Association between breakfast skipping and postprandial hyperglycaemia after lunch in healthy young individuals

  2019cites this paper
• Relationship between HbA1c and capillary blood glucose self-monitoring in type 2 diabetics

  2019cites this paper
• PREVALENCE OF TYPE 2 DIABETES MELLITUS WITH RISK FACTORS OF DIABETIC FOOT IN SAUDI ARABIA

  2019cites this paper